Consensus Interferon and Ribavirin in Patients with Chronic Hepatitis C Who Were Nonresponders to Pegylated Interferon alfa-2b and Ribavirin

被引：0
|
作者：
Carroll B. Leevy
机构：
[1] University of Medicine & Dentistry of New Jersey,Department of Medicine, Division of Gastroenterology/Hepatology
[2] New Jersey Medical School Liver Center,undefined
来源：
Digestive Diseases and Sciences | 2008年 / 53卷 / 7期
关键词：
D O I：
10.1007/s10620-008-0252-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2009 / 2009
相关论文
共 50 条
  • [21] VIROLOGICAL RESPONSE TO TREATMENT WITH PEGYLATED INTERFERON ALFA-2B AND RIBAVIRIN CHRONIC HEPATITIS C IN CHILDREN
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    Jendryczka, Ewa
    HEPATOLOGY, 2008, 48 (04) : 855A - 856A
  • [22] High dose consensus interferon and ribavirin for treatment of chronic Hepatitis C infection in patients who are resistant to PEG-Interferon alfa-2b and ribavirin: Preliminary results
    Fernandez, AA
    Singh, S
    Victor, A
    Santiago, M
    Rothstein, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10): : S93 - S94
  • [23] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [24] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [25] Comparison of pegylated interferon alfa-2a and alfa-2b in combination with ribavirin in obese patients with chronic hepatitis
    Moore, CH
    Angtuaco, TL
    Lindsey, JL
    Nelson, SD
    Malik, AH
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S109 - S109
  • [26] Evaluation of retinopathy in patients with hepatitis C on pegylated interferon alfa-2b and ribavirin: An interim analysis
    Sheinbaum, AJ
    Winn, JM
    Esrason, KT
    GASTROENTEROLOGY, 2003, 124 (04) : A776 - A776
  • [27] The influence of cigarette smoking on response to treatment with pegylated interferon alfa-2b and ribavirin in patients with chronic hepatitis C
    Pauly, Mary P.
    Sheinbaum, Alan J.
    Szpakowski, Jean-Luc I.
    Ready, Joanna B.
    Brown, Robert S.
    Freilich, Bradley
    Afdhal, Nezam
    Kwo, Paul
    Santoro, John
    Becker, Scott
    Jacobson, Ira
    Griffel, Louis
    Brass, Clifford
    GASTROENTEROLOGY, 2006, 130 (04) : A286 - A286
  • [28] Combination therapy with pegylated interferon ALFA-2B and ribavirin for patients with chronic hepatitis C and normal aminotransferase levels
    Kotano, Yoshiaki
    Ishigami, Mosatoshi
    Nakano, Isao
    Hayashi, Kozuhiko
    Honda, Takashi
    Goto, Hidemi
    HEPATOLOGY, 2007, 46 (04) : 397A - 397A
  • [29] Impact of pegylated interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MS
    Albrecht, JK
    HEPATOLOGY, 2001, 34 (04) : 244A - 244A
  • [30] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
12345